Masson Finds Molecules That Might Inhibit Key Enzyme in SARS-CoV-2 Replication
Three Ohio University chemists have found that molecules synthesized in their group might inhibit a key enzyme in SARS-CoV-2 coronavirus replication. Their work could potentially lead to the development of new antiviral drugs against SARS-CoV-2. Dr. Eric Masson, post-doctoral associate Dr. Hector Barbero, and graduate student Nathan Thompson recently showed […]
Read more ›
Comments